FIELD: medicine.
SUBSTANCE: invention relates to treating oncological diseases. Method includes administering an agent preventing angiogenesis in a combination with hypoxically TH-302 prodrug.
EFFECT: efficient treatment of oncological diseases by synergetic action of said preparations.
14 cl, 3 ex, 4 tbl
Title | Year | Author | Number |
---|---|---|---|
PHOSPHORAMIDATE ALKYLATOR PRODRUG | 2006 |
|
RU2414475C2 |
TREATING CANCER WITH COMBINATION OF RADIATION THERAPY, CERIUM OXIDE NANOPARTICLES AND CHEMOTHERAPEUTIC AGENT | 2015 |
|
RU2704811C2 |
USING ALLOPURINOL FOR TREATING PALMAR-PLANTAR ERYTHRODYSESTHESIA SYNDROME | 2010 |
|
RU2543325C2 |
APILIMOD FOR USE IN TREATING RENAL CANCER | 2015 |
|
RU2727802C2 |
METHOD OF TREATING PALMAR-PLANTAR ERYTHRODYSESTHESIA | 2018 |
|
RU2722396C2 |
TREATMENT OF MALIGNANT NEOPLASMS BASED ON CAIX STRATIFICATION | 2014 |
|
RU2663694C2 |
COMPOUNDS AND COMPOSITIONS FOR STABILISATION OF HYPOXIA INDUCED FACTOR-2 ALPHA AS METHOD OF CANCER MEDICAL TREATMENT | 2012 |
|
RU2602498C2 |
COMPLEX ANTIANGIOGENIC AND HYPOXIA-TARGETED ANTITUMOR AGENT | 2022 |
|
RU2804771C1 |
METHOD FOR REDUCING MULTI-DRUG RESISTANCE WITH USING INOSITOL TRIPYROPHOSPHATE | 2010 |
|
RU2563127C2 |
COMBINED TREATMENT METHODS USING ALK INHIBITORS | 2015 |
|
RU2718914C2 |
Authors
Dates
2016-09-20—Published
2011-07-11—Filed